MCC950, the most potent and specific inhibitor of NLRP3, has proven efficacy in many mouse models of NLRP3-driven diseases, such as colitis, NASH, Alzheimer’s disease and other afflictions26–29. This evidence concerns the gene NLRP3 and early-onset autosomal dominant Alzheimer disease.